On 3 March 2025, the AVITHRAPID consortium met HERA during the first AVITHRAPID seminar to foster collaboration and explore new opportunities in the domain of antivirals as response against pandemic infectious diseases.
During the online meeting, Prof. Bjoern Windshuegel and Prof. Vincenzo Summa of the Consortium led the introduction of activities and services of AVITHRAPID project, with perspectives on advancing in the field of the early and late-stage development of antivirals, while Dr. Joao Madera offered an insight of HERA work and achievements in the framework of a needed end-to-end approach for supporting medical countermeasures from R&D to stockpiling.
The seminar was a pivotal opportunity to further invest resources and competences at EU level to prepare for overarching health threat and co-ordinate developments and results. HERA promotes advanced research and innovation to develop effective, safe and affordable countermeasures and in this view the two parts have started a fruitful collaboration.
